Managing your diabetes can help prevent associated vision loss

Although there is no cure, diabetic retinal disease treatment has improved over the past two decades

5:00 AM

Author | Ananya Sen

two photos of the back of an eye
Retinal damage caused by diabetic retinal disease. Getty Images

Diabetes affects more than 1 in 10 adults worldwide and has been accompanied by an increase in vision-threatening diabetic retinal disease (DRD).

Concerningly, DRD is the leading cause of preventable blindness for those aged 20-74 years.

Multiple studies have shown that DRD screening remains challenging because patients often do not have any symptoms in the early stages and, therefore, misunderstand the importance of regular screenings.

In a recent publication in Diabetes Technology & Therapeutics, Thomas Gardner, M.D., M.S., professor of ophthalmology and visual sciences and a member of Caswell Diabetes Institute, discusses current screening recommendations and treatment options for DRD.

Diabetes can damage multiple parts of the body, including kidneys, nerves and eyes. DRD affects the blood vessels and nerve cells in the retina, resulting in hemorrhages, abnormal blood vessel growth and loss of critical nerve cells.

“People usually are not motivated to take action until their vision is threatened, by which time they might develop late-stage DRD,” Gardner said.

The American Diabetes Association therefore recommends that adults with type 2 diabetes have their first eye exam when they are diagnosed and those with type 1 diabetes have their first eye exam within five years of diagnosis.

“The guidelines for type 1 and type 2 diabetes are different because adults who have the latter can develop vision complications before they become aware of their condition,” Gardner said. 

“Importantly, adolescents and young adults are at a higher risk, largely because it is very difficult for them to control their diabetes.”

Diabetes requires constant monitoring of blood sugar and diet.

“Sometimes patients can take the same amount of medication, eat the same food and get the same amount of exercise only to find that their blood sugar levels fluctuate. This makes it hard to manage,” Gardner said.

The biggest challenge for patients is lowering their blood sugar levels without becoming hypoglycemic, which is characterized by shakiness, uneven heartbeat, sweating and dizziness.

Although improvements in insulin pumps and continuous glucose monitors have made it easier to control blood sugar levels, Gardner emphasizes treating the other aspects of diabetes.

“People with diabetes need to have regular health checkups to ensure that their blood pressure is normal and all their organs are functioning correctly. Establishing good control on every facet of diabetes is essential,” he said.

Although the effect of diabetes on the retina is not completely understood, researchers have found several drugs that are promising.

In particular, those that help control blood pressure and lipid levels, including SGLT inhibitors, GLP-1 receptor activators and fenofibrate, can help slow the progression of DRD. However, these are generally prescribed by physicians and not ophthalmologists. 

“Although these drugs were developed to treat other disorders, including kidney disease, heart disease and high cholesterol, ongoing studies have shown they can reduce the risk of vision loss in patients with diabetes,” Gardner said.

As a part of Caswell Diabetes Institute's Mary Tyler Moore Vision Initiative, Gardner and his colleagues are hoping to develop screening techniques that can catch DRD in its early stages and therapies that preserve and restore vision in people with diabetes.

“The prognosis for vision in people with diabetes is better now than it's ever been in the past. There's every reason to be optimistic that vision loss can be avoided with regular screenings and treatment,” Gardner said.

Additional authors: Ryan F. Bloomquist, Ph.D., M.P.H., University of South Carolina and Doan Tam Bloomquist, M.D., Charlie Norwood Veterans Affairs Hospital.

Paper cited: “Current Treatment Options for Diabetic Retinal Disease,” Diabetes Technology & Therapeutics. DOI: 10.1089/dia.2024.0548

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.  


More Articles About:

Eye Care & Vision Diabetes Diabetic Retinopathy Ophthalmology Diabetes Management Metabolism, Endocrinology & Diabetes
Health Lab word mark overlaying blue cells

Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Thomas Gardner

Thomas Gardner

Professor

Related

woman on left smiling and house on right painted white with greenery
Health Lab

Preserving an artist’s vision after diabetic retinal disease

Kim Hartman is an artist with Type 1 diabetes. She started developing vision problems and doctors at Michigan Medicine helped her slow the vision loss and manage it.
Health Lab

Diabetic Retinopathy: Know the Signs, Symptoms and Treatments

People with type 1 and 2 diabetes are at risk of diabetic retinopathy. Learn about diabetic retinopathy symptoms and treatment.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

A hand holding a scoop of protein powder hovering over a cup of water
Health Lab

Supplementing with peptides: Good for extra pep or a needless step?

Health Lab talks to Jorge Ruas, Ph.D., of the U-M Department of Pharmacology, about peptides, how they work and whether supplementing them lends any benefit.
donut with brain character looking at plate
Health Lab

New study reveals a missing step in a weight control pathway that could be targeted for obesity treatment

New research led by Liangyou Rui, Ph.D., of the Department of Molecular & Integrative Physiology at the University of Michigan Medical School outlines a missing step in one of these alternative pathways, an important discovery in the fight against obesity.
Susan Lane, wearing glasses and a dress with blue, red, black, and purple brushstroke designs, stands next to Alan Sugar, who is wearing glasses and a grey blazer with a blue tie. They are standing in a shaded courtyard area with shrubs and a brick wall behind them.
Philanthropy News

Susan J. Lane: Gratitude and Giving

Susan Lane has made a transformational gift to the Department of Ophthalmology and Visual Sciences at Michigan Medicine to support corneal research and patient education.
woman hugging patient in exam room
Health Lab

A unique patient case inspiring research

Mallory Mattison serves as the inspiration behind critical medical research that’s supporting other patients like her with lipodystrophy syndromes
The Hepner family together in what appears to be their living room. The two young adults are seated on a couch and the two parents lean in behind them. All are smiling.
Philanthropy News

March Hoops to BEAT Blindness Marks 20 Years of Community Support for Vision Research

Annual community fundraiser celebrates NCAA basketball excitement while supporting critical vision research at the University of Michigan Health W.K. Kellogg Eye Center.
eye drawing yellow dots
Health Lab

Cell death in photoreceptor cells is reversible, study finds

A team of researchers from the University of Michigan found functional mitochondria are key to the recovery of dying photoreceptor cells.